Archive:
Apr 15, 2021, 12:00 AM
CNYBAC Client Quadrant Biosciences Receives FDA Designation as a "Breakthrough Device" for Clarifi ASD
April
15,
2021
Provided by Richard Uhlig, CEO Quadrant Biosciences
FDA has designated Quadrant Biosciences Clarifi ASD Test a "Breakthrough Device.
Read More »